Ahmad Kamarudin, Anchah Lawrence, Ting Chuo Yew, Lim Su Ee
Miri Hospital and Clinical Research Center Miri, Miri, Sarawak, Malaysia.
Pharmacology Unit, Faculty of Medicine and Health Sciences, University Malaysia Sarawak, Malaysia.
Contemp Clin Trials Commun. 2024 Feb 24;38:101280. doi: 10.1016/j.conctc.2024.101280. eCollection 2024 Apr.
This study presents a protocol for the Pharmacy Integrated Community Care (PICC) program, meticulously designed to enhance Hemoglobin A1c (HbA1c) levels and augment knowledge about diabetes mellitus (DM) among individuals diagnosed with Type 2 Diabetes Mellitus (T2DM) in the Sarawak State of Malaysia.
From 1 May to December 31, 2023, a prospective, multicenter, parallel-design randomised controlled trial will be conducted with two groups, each consisting of 47 participants. The intervention group will receive a structured, four-session group-based program guided by experienced pharmacists, focusing on medication adherence and diabetes management. The control group will follow the standard Diabetes Mellitus Adherence Clinic program. The primary outcomes of this study encompass enhancements in knowledge regarding diabetes medication management and adherence, followed by subsequent changes in HbA1c levels.
The successful implementation of the PICC program holds promise for enhancing health outcomes in the T2DM population, potentially leading to more effective diabetes management initiatives and better health practices in the community.
NCT05106231.
本研究提出了一项药房综合社区护理（PICC）计划方案，该方案经过精心设计，旨在提高马来西亚砂拉越州2型糖尿病（T2DM）患者的糖化血红蛋白（HbA1c）水平，并增加他们对糖尿病（DM）的了解。
2023年5月1日至12月31日，将进行一项前瞻性、多中心、平行设计的随机对照试验，分为两组，每组47名参与者。干预组将接受由经验丰富的药剂师指导的结构化、四节小组课程，重点是药物依从性和糖尿病管理。对照组将遵循标准的糖尿病依从性诊所计划。本研究的主要结果包括糖尿病药物管理和依从性知识的提高，以及随后HbA1c水平的变化。
PICC计划的成功实施有望改善T2DM人群的健康状况，可能会带来更有效的糖尿病管理举措和社区更好的健康实践。
试验注册 临床试验注册号：NCT05106231。
